Accenture (ACN)
(Delayed Data from NYSE)
$323.15 USD
-4.93 (-1.50%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $322.34 -0.81 (-0.25%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum D VGM
Price, Consensus and EPS Surprise
ACN 323.15 -4.93(-1.50%)
Will ACN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ACN
Accenture (ACN) Stock Moves -1.5%: What You Should Know
Should You Invest in the iShares U.S. Industrials ETF (IYJ)?
ACN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Accenture PLC (ACN) is Attracting Investor Attention: Here is What You Should Know
Maximus (MMS) Surges 11% in 3 Months: Should You Buy the Stock?
Omnicom (OMC) Earnings & Revenues Surpass Estimates in Q2
Other News for ACN
5 Relatively Secure And Cheap Dividend Stocks To Invest In -- August 2024
Globant: A Second Stage AI Player
Accenture Acquires BOSLAN to Help Clients Optimize Investments in Net-Zero Infrastructure
Accenture buys engineering firm Boslan
Accenture acquires BOSLAN, terms not disclosed